V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004983 | 300003412 | 1.58 | 62.2 | Curative (C) | 2019-04-03 | 2019-04-26 | GEM-P | N | Y | 300001503 | FLUOROURACIL + MITOMYCIN |
| 300004984 | 300007524 | 1.56 | 37.8 | Palliative (P) | 2019-03-15 | 2019-03-25 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 300001685 | ABVD |
| 300004985 | 300003413 | 1.78 | 80 | Palliative (P) | 2015-05-04 | 2015-05-12 | CARBOPLATIN + FLUOROURACIL | N | N | 300001686 | CARBO + FLUOROURACIL |
| 300004986 | 300003413 | 1.8 | 98.15 | Palliative (P) | 2011-12-15 | 2017-08-26 | Capecitabine + Cisplatin | 2 | N | 300001686 | CARBOPLATIN |
| 300004987 | 300003413 | 1.81 | 79.6 | Palliative (P) | 2016-03-23 | 2016-04-02 | Carboplatin + Etoposide iv&po | N | N | 300001686 | CARBOPLATIN + RT |
| 300004988 | 300003414 | 1.69 | 105 | Palliative (P) | 2016-08-15 | 2016-08-28 | Paclitaxel 7 day | N | N | 300002012 | CAPECITABINE + GEMCITABINE |
| 300004989 | 300003414 | 1.53 | 61 | Curative (C) | 2017-11-19 | 2017-12-08 | Capecitabine + Cisplatin | N | Y | 300002012 | PACLITAXEL |
| 300004990 | 300007526 | 1.68 | 114 | Adjuvant (A) | 2018-12-24 | 2019-01-01 | Carboplatin + Etoposide iv&po | 02 | N | 300002293 | CARBOPLATIN |
| 300004991 | 300003415 | 1.63 | 61.8 | Curative (C) | 2014-12-08 | 2014-12-11 | ESPAC-4 TRIAL | N | Y | 300002393 | CISPLATIN + FLUOROURACIL + RT |
| 300004992 | 300003415 | 1.51 | 60.4 | Curative (C) | 2017-05-15 | 2017-06-15 | Capecitabine (14 days)+Carboplatin | Y | Y | 300002393 | EOX |
| 300004993 | 300003416 | 1.56 | null | Palliative (P) | 2014-05-14 | 2014-05-14 | CARBOPLATIN + GEMCITABINE | N | N | 300002470 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004994 | 300003416 | null | 74.4 | Curative (C) | 2017-12-13 | 2017-12-20 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 01 | N | 300002470 | ESPAC TRIAL |
| 300004995 | 300003417 | 1.88 | 70.4 | null | 2015-06-30 | 2015-07-05 | Gemcitabine + Capecitabine | 2 | Y | 300002553 | CAPECITABINE + OXALIPLATIN |
| 300004996 | 300003417 | 1.57 | 75 | null | 2018-01-14 | 2018-02-08 | FLUOROURACIL + OXALIPLATIN | 02 | N | 300002553 | CAPECITABINE + OXALIPLATIN |
| 300004997 | 300003418 | null | 73.4 | Palliative (P) | 2018-07-05 | 2018-07-13 | PEMBROLIZUMAB | 02 | N | 300002653 | IPILIMUMAB |
| 300004998 | 300003419 | 1.72 | 73.1 | Palliative (P) | 2015-03-15 | 2015-03-16 | GemCarbo Days 1+8 | 02 | N | 300002678 | ESPAC TRIAL |
| 300004999 | 300003420 | 1.62 | 84 | Disease modification (D) | 2017-04-28 | 2017-05-16 | FEC 100 | N | N | 300002700 | FEC |
| 300005000 | 300003420 | 1.64 | 90 | Curative (C) | null | 2013-05-25 | Ipilimumab | Y | Y | 300002700 | GEMCARBO |
| 300005001 | 300003420 | null | 93 | Neo-adjuvant (N) | 2017-12-23 | 2018-01-18 | FLUOROURACIL + MITOMYCIN + RT | N | N | 300002700 | PACLITAXEL |
| 300005002 | 300003421 | 1.68 | 79 | Curative (C) | 2016-10-05 | 2016-10-05 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 300002872 | CAPECITABINE + CARBOPLATIN |
| 300005003 | 300006268 | 1.54 | 62.2 | Palliative (P) | 2017-10-17 | 2017-11-01 | Carboplatin + Etoposide iv&po | 02 | N | 300003188 | GEMCARBO |
| 300005004 | 300003422 | 1.61 | 90 | Adjuvant (A) | 2017-12-03 | 2017-12-20 | FLUOROURACIL | N | Y | 300003195 | CAPECITABINE + CISPLATIN + RT |
| 300005005 | 300003423 | 1.57 | 73 | Palliative (P) | 2017-05-29 | 2017-06-11 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 1 | N | 300003293 | FLUOROURACIL |
| 300005006 | 300006269 | 1.67 | 84 | Curative (C) | 2018-01-15 | 2018-02-04 | CAPECITABINE + CISPLATIN + Trastuzumab | N | Y | 300003300 | CISPLATIN + FLUOROURACIL + RT |
| 300005007 | 300006269 | 1.59 | 54.8 | Palliative (P) | 2016-12-03 | 2016-12-18 | GEMCARBO | N | N | 300003300 | OXALIPLATIN + MDG |
| 300005008 | 300003424 | 1.63 | 49.8 | Palliative (P) | 2016-03-25 | 2016-04-19 | Oxaliplatin + Modified de Gramont | N | Y | 300003409 | CARBOPLATIN + ETOPOSIDE |
| 300005009 | 300003425 | 1.72 | 80 | Adjuvant (A) | 2014-10-02 | 2014-10-06 | CARBOPLATIN + RT | 02 | N | 300003432 | CARBOPLATIN + ETOPOSIDE |
| 300005010 | 300006270 | 1.62 | 74 | Palliative (P) | 2016-12-10 | 2016-12-21 | Carboplatin + Liposomal Doxorubicin | N | N | 300003436 | PACLITAXEL |
| 300005011 | 300003426 | 1.6 | 52.8 | Neo-adjuvant (N) | 2015-06-19 | 2015-06-21 | ESPAC-4 TRIAL | 02 | N | 300003466 | PEMBROLIZUMAB |
| 300005012 | 300003427 | 1.5 | 68.9 | Curative (C) | 2014-07-08 | 2014-07-08 | CARBOPLATIN + GEMCITABINE | 1 | N | 300003498 | CARBOPLATIN + RT |
| 300005013 | 300006271 | 1.72 | 56.7 | Adjuvant (A) | 2018-07-18 | 2018-08-19 | FEC 100 | Y | N | 300003545 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005014 | 300006271 | 1.81 | 60.7 | Curative (C) | 2017-03-11 | 2017-03-12 | Capecitabine + Oxaliplatin 21day | 2 | N | 300003545 | ESPAC TRIAL |
| 300005015 | 300006271 | 1.6 | 59.2 | Palliative (P) | 2017-09-09 | 2017-09-12 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 300003545 | CAPECITABINE + GEMCITABINE |
| 300005016 | 300006271 | 1.71 | null | Palliative (P) | 2018-01-03 | 2018-01-16 | Paclitaxel 7 day | N | N | 300003545 | PEMBROLIZUMAB |
| 300005017 | 300003428 | 1.56 | 68.3 | Palliative (P) | 2018-02-06 | 2018-04-06 | CARBOPLATIN + RT | N | N | 300003749 | IDELALISIB |
| 300005018 | 300003428 | 1.8 | 74 | Palliative (P) | 2013-08-28 | 2013-10-28 | Carboplatin AUC 2 - 5 | N | N | 300003749 | ESPAC TRIAL |
| 300005019 | 300003429 | 1.74 | 82.4 | null | 2017-10-23 | 2017-10-28 | Carboplatin + Cetux + FU (>Cycle 2) | null | null | 300003970 | NOT MATCHED |
| 300005020 | 300003430 | 1.52 | null | Neo-adjuvant (N) | 2015-12-14 | 2015-12-14 | GEMCITABINE + NAB PACLITAXEL | 2 | N | 300003989 | CISPLATIN + FLUOROURACIL + RT |
| 300005021 | 300003431 | 1.66 | 54 | Disease modification (D) | 2015-11-08 | 2015-11-08 | Carboplatin AUC 6 - 10 | 02 | N | 300004052 | ESPAC TRIAL |
| 300005022 | 300003432 | null | 73 | Curative (C) | 2014-02-07 | 2014-02-08 | CompARE Trial | 02 | Y | 300004180 | CARBOPLATIN |
| 300005023 | 300003433 | 1.51 | 95 | Palliative (P) | 2017-04-13 | 2017-04-18 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 300004188 | CARBO + FLUOROURACIL |
| 300005024 | 300006273 | 1.65 | null | Palliative (P) | 2016-07-27 | 2016-09-14 | Carboplatin AUC 6 - 10 | N | N | 300004204 | OXALIPLATIN + MDG |
| 300005025 | 300003434 | 1.6 | 69 | Curative (C) | 2016-11-23 | 2016-12-17 | Carboplatin AUC 2 - 5 | Y | Y | 300004236 | CISPLATIN + ETOPOSIDE |
| 300005026 | 300006274 | null | 55 | Palliative (P) | 2016-05-27 | 2016-07-11 | CHOP R - 21 days | 2 | N | 300004389 | CARBO + FLUOROURACIL |
| 300005027 | 300003435 | 1.68 | 78.6 | Curative (C) | 2014-08-22 | 2014-08-27 | FLUOROURACIL + MITOMYCIN + RT | 02 | Y | 300004487 | FLUOROURACIL + MITOMYCIN |
| 300005028 | 300003436 | 1.7 | 90 | Adjuvant (A) | 2017-05-24 | 2017-06-05 | Paclitaxel (2 or 3 weekly) | N | N | 300004490 | FLUOROURACIL + MITOMYCIN + RT |
| 300005029 | 300006275 | null | 88 | Palliative (P) | 2019-06-05 | 2019-06-17 | PEMBROLIZUMAB | N | N | 300004598 | CAPECITABINE + CISPLATIN |
| 300005030 | 300006275 | 1.76 | 73.7 | null | 2019-02-01 | 2019-02-05 | CompARE Trial | 01 | N | 300004598 | CARBOPLATIN + RT |
| 300005031 | 300003437 | 1.48 | null | null | 2016-11-23 | 2016-11-29 | GEMCARBO | Y | N | 300004613 | GEMCITABINE + OXALIPLATIN |
| 300005032 | 300003437 | 1.73 | 76.9 | null | null | 2015-12-02 | Cisplatin + Fluorouracil + RT 5day | null | null | 300004613 | OXALIPLATIN + MDG |